Bryan Williams
Fortune : 102 320 $ au 31/05/2026
Fortune : 102 320 $ au 31/05/2026
Bryan Raymond George Williams currently works at Hudson Institute of Medical Research, as Chief Executive Officer & Director, MIMR-PHI Institute of Medical Research, as Chief Executive Officer & Director, Pacific Edge Ltd., as Deputy Chairman, BioGrid Australia Ltd., as Chairman, EnGeneIC Pty Ltd., as Director, Pacific Edge Diagnostics USA Ltd., as Director, Zehna Therapeutics, Inc., as Director, Pacifik Biopharma Ltd., as Director, Cancer Trials Australia, as Director, Pacific Edge Diagnostics Singapore Pte Ltd., as Director, Xynapse Therapeutics Pty Ltd., as Director, and Cartherics Pty Ltd., as Director.
Dr. Williams also formerly worked at Lite Strategy, Inc., as Non-Executive Chairman from 2006 to 2013, Cleveland Clinic Lerner Research Institute, as Chairman-Department of Cancer Biology in 2005, The Cleveland Clinic Foundation, as Chairman-Department of Cancer Biology in 2005, The Ritz-Carlton Hotel Co. LLC, as Global Director-Organizational Effectiveness, Monash Institute of Medical Research, as Director from 2006 to 2013, Pacific Edge Pty Ltd., as Director, Case Western Reserve University, as Professor-Department of Genetics in 2005, Cleveland State University, as Adjunct Professor from 1998 to 2005, and Kent State University (Ohio), as Adjunct Professor in 2005.
Dr. Williams received his undergraduate degree and doctorate degree from the University of Otago.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PACIFIC EDGE LIMITED 0,05 % | 31/03/2025 | 610 357 ( 0,05 % ) | 102 320 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PACIFIC EDGE LIMITED | Directeur/Membre du Conseil | 04/07/2013 |
MIMR-PHI Institute of Medical Research | Directeur Général | - |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases | Directeur/Membre du Conseil | - |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Directeur/Membre du Conseil | - |
Cartherics Pty Ltd.
Cartherics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing cancer therapies | Directeur/Membre du Conseil | - |
Xynapse Therapeutics Pty Ltd. | Directeur/Membre du Conseil | - |
Pacific Edge Diagnostics Singapore Pte Ltd. | Directeur/Membre du Conseil | - |
Hudson Institute of Medical Research
Hudson Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides reproductive and baby health research services | Directeur/Membre du Conseil | 01/01/2013 |
BioGrid Australia Ltd. | Président | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 21 |
|---|---|
Pacific Edge Ltd.
Pacific Edge Ltd. BiotechnologyHealth Technology Develops diagnostic and prognostic products for human cancer | Health Technology |
MEI Pharma, Inc.
MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleveland State University
Cleveland State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kent State University (Ohio)
Kent State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ritz-Carlton Hotel Co. LLC
The Ritz-Carlton Hotel Co. LLC Hotels/Resorts/Cruise linesConsumer Services Owns and operates hotels and resorts | Consumer Services |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Cleveland Clinic Lerner Research Institute
Cleveland Clinic Lerner Research Institute Miscellaneous Commercial ServicesCommercial Services Provides laboratory-based, translational and clinical research services | Commercial Services |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Cancer Trials Australia | |
Monash Institute of Medical Research | |
Pacific Edge Diagnostics USA Ltd.
Pacific Edge Diagnostics USA Ltd. Medical/Nursing ServicesHealth Services Manages and operates laboratories used for the detection of bladder cancer | Health Services |
Pacific Edge Pty Ltd. | |
MIMR-PHI Institute of Medical Research | |
BioGrid Australia Ltd. | |
Hudson Institute of Medical Research
Hudson Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides reproductive and baby health research services | Commercial Services |
Pacific Edge Diagnostics Singapore Pte Ltd. | |
Xynapse Therapeutics Pty Ltd. | |
Cartherics Pty Ltd.
Cartherics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing cancer therapies | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national